Skip to content
EU Parl Watch

Changes between two versions

What changed between the plenary report and the adopted text

From · plenary report· 16 Apr 2026

A-10-2026-0093

on the proposal for a regulation of the European Parliament and of the Council on the European Chemicals Agency and amending Regulations (EC) No 1907/2006, (EU) No 528/2012, (EU) No 649/2012 and (EU) 2019/1021

To · adopted text· 29 Apr 2026

TA-10-2026-0140

European Chemicals Agency and amending Regulations

AI:What changed, in short

The main change is a new recital enabling staff secondment to national authorities, expanding the Agency's operational flexibility.1 The other change is a wording clarification in Article 37, adjusting a cross-reference without altering substance.2

1 change of substance · 0 formal · 1 of wording only

Written by AI from the two texts only · read the changes before relying on it · 4 Sept 2026 · Report a problem

+5 added · −44 removed · 2 changed paragraphs, packaging included.

Part 3 of 5: Paragraphs 121–136

16 unchanged paragraphs

Article 44 – paragraph 1 d (new): 1d. The Agency shall coordinate the work of the task force for 12 months after the task force is established. The coordination and chairing of the work of the taskforce, including leading the coordination of the task force meetings and activities shall rotate among the agencies every 12 months thereafter in accordance with its framework for action referred to in paragraph 1l.

Article 44 – paragraph 1 e (new): 1e. The task force shall consist of staff from each agency referred to in paragraph 1b. The Executive Director of each agency shall appoint a representative to the task force and the representatives shall report to their respective Executive Directors on progress. A representative from the Commission shall be invited to participate in the meetings of the task force to ensure close cooperation between the task force and the Commission.

Article 44 – paragraph 1 f (new): 1f. Each agency referred to in paragraph 1b shall establish a focal point within that agency to coordinate its respective input to joint activities and convey the position of that agency on strategic matters. Each focal point shall keep its own management and interagency mechanisms informed of relevant developments under the task force.

Article 44 – paragraph 1 g (new): 1g. Task force members may seek to engage other representatives from within each agency for input and advice to support the implementation of the actions, as needed.

Article 44 – paragraph 1 h (new): 1h. Observers and external experts may attend meetings of the task force as and when required, in agreement with the members of the task force.

Article 44 – paragraph 1 i (new): 1i. The task force shall not act as a decision-making body. The task force may propose recommendations for action to the senior management of the agencies. Representatives of each agency in the task force shall have an advisory role to the Executive Directors and senior management of its own agency and shall engage with the Commission and other stakeholders for input and advice, as appropriate.

Article 44 – paragraph 1 j (new): 1j. The task force shall meet at least six times a year, with at least one annual physical meeting of a more strategic nature. Ad hoc meetings may be organised, as needed.

Article 44 – paragraph 1 k (new): 1k. By 31 December each year, members of the task force shall draw up and endorse an annual framework for action describing a plan for the joint One Health and exposome work of the agencies referred to in paragraph 1b. / The framework for action shall include objectives to be pursued by the task force, concrete actions and outcomes to achieve them, and an approximate timeline for the implementation of such actions, and shall be built around the following objectives with regards to One Health and exposome: / (a) facilitate strategic coordination in its implementation; / (b) promote research coordination; / (c) enhance capacity building; / (d) strengthen communication and stakeholders' engagement; / (e) support the development of joint partnerships.

Article 44 – paragraph 1 l (new): 1l. The framework for action referred to in paragraph 1l shall be consistent with the respective mandates of each agency and shall not hinder their statutory activities.

Article 45 – paragraph 2: 2. Where the Agency identifies a potential source of divergence as referred to in paragraph 1, it shall contact the other body concerned in order to ensure that all relevant scientific or technical information is shared and in order to identify the potentially contentious scientific or technical issues.

Article 45 – paragraph 3: 3. The Agency and the other body concerned shall cooperate to resolve the divergence, taking into consideration the objective of a high level of protection of health and the environment. If the Agency and the other body concerned are not able to resolve the divergence, they shall draw up a joint report. The report shall clearly outline the contentious scientific issues, identify the relevant uncertainties in the data and give the underlying reasons for the divergence of opinions, including reasons related to methodological differences. The report shall be made publicly available. Where the other body concerned is a Union agency or a scientific committee, the Agency shall also present the joint report to the Commission.

Article 46: deleted / (deleted) / (deleted) / (deleted) / (deleted) / (deleted) / (deleted) / (deleted)

Article 48 – paragraph 1 – point 3: (3) in Article 77, paragraph 1, and paragraph 3, points (b), and (c), are deleted;

Article 54 – title: Evaluation and review

Article 54 – paragraph 2: 2. The evaluation shall address the possible need to modify the mandate of the Agency, and the financial implications of any such modification. The evaluation shall also assess the functioning of the Committees and whether it would be appropriate to align or adapt Articles 14 and 15 of this Regulation.

Article 54 – paragraph 3: 3. The Commission shall report to the European Parliament, to the Council, and to the Management Board on the findings of the evaluation. An action plan and a timetable shall be included, if appropriate. The Commission shall, where appropriate, submit a legislative proposal to the European Parliament and to the Council. The findings of the evaluation shall be made public by the Commission.